Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kezar Life Sciences Inc (DE:2KZ)
FRANKFURT:2KZ
RESEARCH TOOLSreports
Holding DE:2KZ?
Track your performance easily
See the Price Targets and Ratings of:
2KZ Analyst Ratings
Moderate Buy
1 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
2KZ Stock 12 Month Forecast
Average Price Target
€4.16
▲(622.78% Upside)
| Highest Price Target€6.46 | Average Price Target€4.16 | Lowest Price Target€1.85 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
07/22/24
Wells Fargo
Reiterated
05/09/24
JonesTrading
―
Hold
―
Reiterated
04/04/24
Kezar reported 4Q23 earnings ( press release ). There were no material updates and key milestones are on track: Ph2b PALIZADE data in LN in mid-26 and Ph2a PORTOLA data in autoimmune hepatitis in mid-25. Workforce reduction of 41% in 4Q23 extends cash runway into late 2026, which is importantly beyond the all key topline readouts. We are still positive on zeto efficacy in future readouts, but see the lack of near term catalysts as a headwind for KZR shares. Reiterate HOLD.
TD Cowen
―
Buy
―
Reiterated
03/25/24
Analysts' Opinions Are Mixed on These Healthcare Stocks: Kezar Life Sciences (NASDAQ: KZR), Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF) and Cue Health (NASDAQ: HLTH)
Best Analysts Covering Kezar Life Sciences
Which Analyst Should I Follow If I Want to Buy DE:2KZ and Sell After:
1 Month
xxx
Success Rate
7/14 ratings generated profit
Average Return
-4.63%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -4.63% per trade.
3 Months
xxx
Success Rate
8/14 ratings generated profit
Average Return
-1.79%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of -1.79% per trade.
1 Year
Success Rate
4/14 ratings generated profit
Average Return
-20.10%
reiterated a buy rating 4 months ago
Copying Phil Nadeau's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -20.10% per trade.
2 Years
xxx
Success Rate
5/14 ratings generated profit
Average Return
+7.51%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 35.71% of your transactions generating a profit, with an average return of +7.51% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
2KZ Analyst Recommendation Trends
Rating
Feb 24
Mar 24
Apr 24
May 24
Jul 24
Strong Buy
3
3
2
2
2
Buy
1
1
1
1
0
Hold
1
0
1
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
4
4
5
4
Each month's total comprises the sum of three months' worth of ratings.
2KZ Financial Forecast
2KZ Stock Forecast FAQ
What is DE:2KZ’s average 12-month price target, according to analysts?
Based on analyst ratings, Kezar Life Sciences Inc’s 12-month average price target is €4.16.
What is DE:2KZ’s upside potential, based on the analysts’ average price target?
Kezar Life Sciences Inc has 622.78% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Kezar Life Sciences Inc a Buy, Sell or Hold?
Kezar Life Sciences Inc has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is Kezar Life Sciences Inc’s share price target?
The average share price target for Kezar Life Sciences Inc is €4.16. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €6.46 ,and the lowest forecast is €1.85. The average share price target represents 622.78% Increase from the current price of €0.575.
The highest analyst share price target is €6.46 ,and the lowest forecast is €1.85. The average share price target represents 622.78% Increase from the current price of €0.575.
What do analysts say about Kezar Life Sciences Inc?
Kezar Life Sciences Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Kezar Life Sciences Inc?
To buy shares of DE:2KZ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.